Radioimmunoassay Market

Radioimmunoassay Market is valued around USD 398.19 Million in 2018 and expected to reach USD 496.92 Million by 2025 with the CAGR of 3.8% over the forecast period.

Increased prevalence of cancer & infectious disease and increase in research activities are the key drivers for Global Radioimmunoassay Market.

Scope of the Radioimmunoassay Market Report:

Radioimmunoassay market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about radioimmunoassay market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, application type and end user.

Radioimmunoassay is a medical diagnostic procedure used for the quantification of specific antigens and antibody. It is a very sensitive procedure which can also be used for the quantification of very small amount of biological substance. Radioimmunoassay is used for the early detection of cancer and various other diseases. It is also used for research purposes and in pharmaceutical industry for testing of drugs.

There are various factors driving the growth of the radioimmunoassay market, one of the major factors driving the growth of the market is increase in the prevalence of cancer and infectious disease coupled with increased demand of automated procedure to error free results. Furthermore, Increase in various technological advancements for better diagnosis is expected to fuel the growth of radioimmunoassay market over the forecast period. Moreover, increased use of  in the research laboratories pharmaceutical industries, contract research organizations and others is also expected to support the growth of radioimmunoassay market. However, high cost of equipment and dealing with radioactive materials are expected inhibit the growth of radioimmunoassay market over the forecast period.

Key Players of the Radioimmunoassay Market Report:

• Beckman Coulter Inc.
• Berthold Technologies GmbH
• IBL Internationa
• DRG International Inc.
• MP Biomedicals LLC
• PerkinElmer Inc
• Cisbi
• Euro Diagnostica AB
• DIAsource ImmunoAssays
• DiaSorin S.p.A.
• EMD Millipore
• Izotop

Segmentation of Radioimmunoassay Market:

By Product Type

• Kits and Reagents
• Analyzers

By Application

• Scientific Research
• Medical Diagnosis

By End-User

• Academic Research Institute
• Contract Research Organizations
• Hospitals
• Pharmaceutical and Biotechnology Industry

By Region

• North America
  • U.S
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Southeast Asia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2018:	USD 398.19 Million
Base year considered	2021
Forecast Period CAGR %:	3.8%
Market Size Expected in 2025:	USD 496.92 Million
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Beckman Coulter Inc.,Berthold Technologies GmbH, IBL Internationa ,DRG International Inc. ,MP Biomedicals LLC ,PerkinElmer Inc ,Cisbi, Euro Diagnostica AB ,DIAsource ImmunoAssays, DiaSorin S.p.A. ,EMD Millipore ,Izotop
Segments Covered	By Product Type, By Application, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa